Efficacy of naltrexone in smoking cessation: A preliminary study and an examination of sex differences

Nicotine and Tobacco Research

Volumn 8, Issue 5, 2006, Pages 671-682

  King, Andrea ^a   de Wit, Harriet ^a   Riley, Roslynn C ^a   Cao, Dingcai ^a   Niaura, Raymond ^b   Hatsukami, Dorothy ^c  

^a UNIVERSITY OF CHICAGO   (United States)

^b BROWN UNIVERSITY   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEPADE; NALTREXONE; NICOTINE; NICOTINE PATCH; PLACEBO;

ADJUVANT THERAPY; ADULT; AGITATION; ANXIETY DISORDER; ARTHRALGIA; ARTICLE; BEHAVIOR THERAPY; BODY WEIGHT DISORDER; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DIZZINESS; DOSE CALCULATION; DOUBLE BLIND PROCEDURE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; FEMALE; FLUSHING; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; INSOMNIA; LIBIDO DISORDER; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; MYALGIA; NAUSEA; NICOTINE REPLACEMENT THERAPY; PATIENT COMPLIANCE; PATIENT COUNSELING; PENIS ERECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEDATION; SEX DIFFERENCE; SEXUAL INTERCOURSE; SIDE EFFECT; SKIN IRRITATION; SMOKING CESSATION; STATISTICAL SIGNIFICANCE; TOBACCO DEPENDENCE; TREATMENT DURATION; TREATMENT OUTCOME; URTICARIA; VOMITING; WEIGHT GAIN; WITHDRAWAL SYNDROME;

ADULT; AGED; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; NALTREXONE; NARCOTIC ANTAGONISTS; SEX CHARACTERISTICS; SMOKING CESSATION; TREATMENT OUTCOME;

EID: 33749262497     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1080/14622200600789767     Document Type: Article

References (64)

1. Abrams, D. B. and Niaura, R. and Brown, R. A. and Emmons, K. M. and Goldstein, M. G. and Monti, P. M. (2003). In Tobacco dependence treatment handbook: A guide to best practices. New York: Guilford Press.
2. Ahluwalia, J. S. and McNagny, S. E. and Clark, W. S. (1998) Smoking cessation among inner-city African-Americans using the nicotine transdermal patch. Journal of General Internal Medicine, 13, pp. 1-8.
3. Almeida, L. E. F. and Pereira, E. F. R. and Alkondon, M. and Fawcett, W. P. and Randall, W. R. and Albuquerque, E. X. (2000) The opioid antagonist naltrexone inhibits activity and alters expression of α7 and α4β2 nicotinic receptors in hippocampal neurons: Implications for smoking cessation programs. Neuropharmacology, 39, pp. 2740-2755.
4. Beck, A. T. and Ward, C. H. and Menderson, M. and Mack, J. and Erbaugh, J. (1961) An inventory for measuring depression. Archives of General Psychiatry, 4, pp. 561-571.
5. Biener, L. and Abrams, D. B. (1991) The contemplation ladder: Validation of a measure of readiness to consider smoking cessation. Health Psychology, 10, pp. 360-365.
6. Bjornson, W. and Rand, C. and Connett, J. E. and Lindgren, P. and Nides, M. and Pope, F. and Buist, A. S. and Hoppe-Ryan, C. and O'Hara, P. (1995) Gender differences in smoking cessation after 3 years in the Lung Health Study. American Journal of Public Health, 85, pp. 223-230.
7. Brauer, L. H. and Behm, F. M. and Westman, E. C. and Patel, P. and Rose, J. E. (1999) Naltrexone blockade of nicotine effects in cigarette smokers. Psychopharmacology, 143, pp. 339-346.
8. Cepeda-Benito, A. and Reynoso, J. T. and Erath, S. (2004) Meta-analysis of the efficacy of nicotine replacement therapy for smoking cessation: Differences between men and women. Journal of Consulting and Clinical Psychology, 72, pp. 712-722.
9. Covey, L. S. and Glassman, A. H. and Stetner, F. (1999) Naltrexone effects on short-term and long-term smoking cessation. Journal of Addictive Diseases, 18, pp. 31-40.
10. Cox, L. S. and Tiffany, S. T. and Christen, A. G. (2001) Evaluation of the Brief Questionnaire of Smoking Urges (QSU-brief) in laboratory and clinical settings. Nicotine & Tobacco Research, 3, pp. 7-16.
11. 3 receptor antagonist sulpiride on self-administration of morphine into the ventral tegmental area or the nucleus accumbens. Psychopharmacology, 160, pp. 307-317.
12. Dhart, R. K. and Gudehithlu, K. P. and Wemlinger, T. A. and Tejwani, G. A. and Neff, N. H. and Hadjiconstannou, M. (1995) Preproenkephalin mRNA and methionine-enkephalin content are increased in mouse striatum after treatment with nicotine. Journal of Neurochemistry, 64, pp. 1878-1883.
13. Epstein, A. M. and King, A. C. (2004) Naltrexone attenuates acute cigarette smoking behavior. Pharmacology, Biochemistry, and Behavior, 77, pp. 29-37.
14. Fiore, M. C. and Bailey, W. C. and Cohen, S. J. and Dorfman, S. F. and Gritz, E. R. and Heyman, R. B. and Holbrook, J. and Jaen, C. R. and Kottke, T. E. and Lando, H. A. and Mecklenbur, R. and Mullen, P. D. and Nett, L. M. and Robinson, L. and Stitzer, M. and Tommasello, A. C. and Villejo, L. and Wewers, M. E. (2000). In Treating tobacco use and dependence. Clinical practice guideline. Rockville MD: U.S. Department of Health and Human Services. Public Health Service.
15. First, M. B. and Spitzer, R. L. and Gibbon, M. and Williams, J. B. W. (1995). In Structured Clinical Interview for DSM-IV Axis I Disorders-Patient edition (SCID-I/P, Version 2.0). New York: Biometrics Research Department.
16. French, S. A. and Jeffrey, R. W. (1995) Weight concerns and smoking: A literature review. Annals of Behavioral Medicine, 71, pp. 234-244.
17. Gianutsos, G. and Drawbaugh, R. and Hynes, M. and Lal, H. (1975) The narcotic withdrawal syndrome in the rat. In Methods in narcotic research. (pp. 293-309). New York: Dekker.
18. Gysling, K. and Wang, R. Y. (1983) Morphine-induced activation of A 10 dopamine neurons in the rat. Brain Research, 277, pp. 119-127.
19. Hatsukami, D. K. and Skoog, K. and Allen, S. and Bliss, R. (1995) Gender and the effects of different doses of nicotine gum on tobacco withdrawal symptoms. Experimental and Clinical Psychopharmacology, 3, pp. 163-173.
20. Heatherton, T. F. and Kozlowski, L. T. and Frecker, R. C. and Fagerström, K.-O. (1991) The Fagerström Test for Nicotine Dependence: A revision of the Fagerström Tolerance Questionnaire. British Journal of Addiction, 86, pp. 1119-1127.
21. Houdi, A. A. and Pierzchala, K. and Marson, L. and Palkovits, M. and Van Loon, G. R. (1991) Nicotine-induced alteration in Tyr-Gly-Gly and met-enkephalin in discrete brain nuclei reflects altered enkephalin neuron activity. Peptides, 12, pp. 161-166.
22. Houtsmuller, E. J. and Clemmy, P. A. and Sigler, L. A. and Stitzer, M. L. (1997) Effects of naltrexone on smoking and abstinence. In Problems of drug dependence 1996, Proceedings of the 58th Annual Scientific Conference. Washington DC: U.S. Department of Health and Human Services. (NIDA Research Monograph No. 174)
23. Hughes, J. R. and Hatsukami, D. (1986) Signs and symptoms of tobacco withdrawal. Archives of General Psychiatry, 43, pp. 289-294.
24. Hughes, J. R. and Hatsukami, D. (1998) Errors in using tobacco withdrawal scale. Tobacco Control, 7, pp. 92-93.
25. Hughes, J. R. and Kelly, J. P. and Niaura, R. S. and Ossip-Klein, D. J. and Richmond, R. L. and Swan, G. E. (2003) Measures of abstinence in clinical trials: Issues and recommendation. Nicotine & Tobacco Research, 5, pp. 13-25.
26. Hutchison, K. E. and Monti, P. M. and Rohsenow, D. J. and Swift, R. M. and Colby, S. M. and Gnys, M. and Niaura, R. S. and Sirota, A. D. (1999) Effects of naltrexone with nicotine replacement on smoking cue reactivity: Preliminary results. Psychopharmacology, 142, pp. 139-143.
27. Jorenby, D. E. and Leischow, S. J. and Nides, M. A. and Rennard, S. I. and Johnston, J. A. and Hughes, A. R. and Smith, S. S. and Muramoto, M. L. and Daughton, D. M. and Doan, K. and Fiore, M. C. and Baker, T. B. (1999) A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. The New England Journal of Medicine, 340, pp. 685-691.
28. King, A. C. (2002) Role of naltrexone in initial smoking cessation: Preliminary findings. Alcoholism: Clinical and Experimental Research, 26, pp. 1942-1944.
29. King, A. C. and Meyer, P. J. (2000) Naltrexone alteration of acute smoking response in nicotine-dependent subjects. Pharmacology, Biochemistry, and Behavior, 66, pp. 563-572.
30. King, A. C. and Riley, R. (2001) Stop smoking manual. In The University of Chicago Studies on Smoking Cessation. Chicago: University of Chicago.
31. King, A. C. and Volpicelli, J. R. and Gunduz, M. and O'Brien, C. P. and Kreek, M. J. (1997) Naltrexone biotransformation and incidence of subjective side effects: A preliminary study. Alcoholism: Clinical and Experimental Research, 21, pp. 906-909.
32. Klesges, R. C. and Somes, G. and Pascale, R. W. and Klesges, L. M. and Murphy, M. and Brown, K. and Williams, E. (1988) Knowledge and beliefs regarding the consequences of cigarette smoking and their relationship to smoking status in a biracial sample. Health Psychology, 7, pp. 387-401.
33. Korslund, K. and Bowen, D. J. (1995) Body weight and body image as predictors of smoking cessation. Annals of Behavioral Medicine, 16((Suppl.)), pp. S153.
34. Krishnan-Sarin, S. and Meandzija, B. and O'Malley, S. (2003) Naltrexone and nicotine patch in smoking cessation: A preliminary study. Nicotine & Tobacco Research, 5, pp. 851-857.
35. Liang, K. Y. and Zeger, S. L. (1986) Longitudinal data analysis using generalized linear models. Biometrika, 73, pp. 13-22.
36. Malin, D. and Lake, J. and Carter, V. and Cunningham, J. and Wilson, O. (1993) Naloxone precipitates nicotine abstinence syndrome. Psychopharmacology, 112, pp. 339-342.
37. Matthews, R. T. and German, D. C. (1984) Electrophysiological evidence for excitation of rat ventral tegmental area dopamine neurons by morphine. Neuroscience, 11, pp. 129-152.
38. Meyers, A. W. and Klesges, R. C. and Winders, S. E. and Ward, K. D. and Peterson, B. A. and Eck, L. H. (1997) Are weight concerns predictive of smoking cessation? A prospective analysis. Journal of Consulting and Clinical Psychology, 65, pp. 448-452.
39. Mizes, J. S. and Sloan, D. M. and Segraves, K. and Bring, B. and Pingitore, R. and Kristeller, J. (1998) The influence of weight-related variables on smoking cessation. Behavior Therapy, 29, pp. 371-385.
40. Nemeth-Coslett, R. and Griffiths, R. R. (1986) Naloxone does not affect cigarette smoking. Psychopharmacology, 89, pp. 261-264.
41. O'Malley, S. S. and Cooney, J. L. and Krishnan-Sarin, S. and Dubin, J. A. and McKee, S. A. and Cooney, N. L. and Blakeslee, A. and Meandzija, B. and Romano-Dahlgard, D. and Wu, R. and Makuch, R. and Jatlow, P. (2006) A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation. Archives of Internal Medicine, 166, pp. 667-674.
42. O'Malley, S. S. and Krishnan-Sarin, S. and Meandzija, B. (1997). In Naltrexone treatment of nicotine dependence: A preliminary study [pp.]. Poster presented at third annual scientific conference of the Society for Research on Nicotine and Tobacco, Nashville, TN
43. Opitz, K. and Weischer, M. L. (1988) Volitional oral intake of nicotine in Tupaias: Drug-induced alterations. Drug and Alcohol Dependence, 21, pp. 99-104.
44. Piasecki, T. M. and Niaura, R. and Shadel, W. G. and Abrams, D. and Goldstein, M. and Fiore, M. C. and Baker, T. B. (2000) Smoking withdrawal dynamics in unaided quitters. Journal of Abnormal Psychology, 109, pp. 74-86.
45. Pierzchala, K. and Houdi, A. A. and Van Loon, G. R. (1987) Nicotine-induced alterations in brain regional concentrations of native and cryptic Met and Leu-enkephalins. Peptides, 8, pp. 1035-1043.
46. Pomerleau, O. F. (1998) Endogenous opioids and smoking: A review of progress and problems. Psychoneuroendocrinology, 23, pp. 115-130.
47. Pomerleau, O. F. and Fertig, J. B. and Seyler, L. E. and Jaffe, J. (1983) Neuroendocrine reactivity to nicotine in smokers. Psychopharmacology, 81, pp. 61-67.
48. Rohsenow, D. J. and Monti, P. M. and Colby, S. M. and Gulliver, S. B. and Swift, R. M. and Abrams, B. (2003) Naltrexone treatment for alcoholics: Effect on cigarette smoking rates. Nicotine & Tobacco Research, 5, pp. 231-236.
49. Royce, J. M. and Corbett, K. and Sorensen, G. and Ockene, J. (1997) Gender, social pressure, and smoking cessation: The Community Intervention Trial for Smoking Cessation (COMMIT) at baseline. Social Science & Medicine, 44, pp. 359-370.
50. Scharf, D. and Shiffman, S. (2004) Are there gender differences in smoking cessation, with and without bupropion? Pooled-and meta-analyses of clinical trials of bupropion SR. Society for the Study of Addiction, 99, pp. 1462-1469.
51. Selzer, M. L. and Vinokur, A. and Can Rooijen, L. A. (1975) A self-administered Short Michigan Alcoholism Screening Test (SMAST). Journal of Studies on Alcohol, 36, pp. 117-126.
52. Senore, C. and Battista, R. N. and Shapiro, S. H. and Segnan, N. and Ponti, A. and Rosso, S. and Aimar, D. (1998) Predictors of smoking cessation following physicians' counseling. Preventive Medicine, 27, pp. 412-421.
53. Sobell, L. C. and Maisto, S. A. and Sobell, M. B. and Cooper, A. M. (1979) Reliability of alcohol abusers' self-reports of drinking behavior. Behavior Research and Therapy, 17, pp. 157-160.
54. Sobell, L. C. and Sobell, M. B. (1995). In Alcohol timeline follow-back users' manual. Toronto: Addiction Research Foundation.
55. Streater, J. A. and Sargent, R. G. and Wand, D. S. (1989) A study of factors associated with weight change in women who attempt smoking cessation. Addictive Behaviors, 14, pp. 523-530.
56. Strecher, V. J. and Rimer, B. (1999). In Freedom from Smoking Guide. New York: American Lung Association.
57. Sutherland, G. and Stapleton, J. A. and Russell, M. A. H. and Feyerabend, C. (1995) Naltrexone, smoking behaviour, and cigarette withdrawal. Psychopharmacology, 120, pp. 418-425.
58. Swan, G. E. and Ward, M. M. and Carmelli, D. and Jack, L. M. (1993) Differential rates of relapse in subgroups of male and female smokers. Journal of Clinical Epidemiology, 46, pp. 1041-1053.
59. Tripathi, H. L. and Martin, B. R. and Aceto, M. D. (1982) Nicotine-induced antinociception in rats and mice: Correlation with nicotine brain levels. Journal of Pharmacology and Experimental Therapeutics, 221, pp. 91-96.
60. U.S. Department of Health and Human Services. (2000). In Reducing tobacco: A report of the surgeon general. Washington DC: U.S. Government Printing Office.
61. Volpicelli, J. R. and Alterman, A. I. and Hayashida, M. and O'Brien, C. P. (1992) Naltrexone in the treatment of alcohol dependence. Archives of General Psychiatry, 49, pp. 876-880.
62. Wetter, D. W. and Kenford, S. L. and Smith, S. S. and Fiore, M. C. and Jorneby, D. E. and Baker, T. B. (1999) Gender differences in smoking cessation. Journal of Consulting and Clinical Psychology, 67, pp. 555-562.
63. Wewers, M. E. and Dhatt, R. and Tejwani, G. A. (1998) Naltrexone administration affects ad libitum smoking behavior. Psychopharmacology, 140, pp. 185-190.
64. Wong, G. Y. and Wolter, T. D. and Croghan, G. A. and Croghan, I. T. and Offord, K. P. and Hurt, R. D. (1999) A randomized trial of naltrexone for smoking cessation. Addiction, 94, pp. 1227-1237.